We are live on ! Find out more
CC

Cannell & Co Portfolio holdings

AUM $3.15B
1-Year Est. Return 30.62%
This Fund
S&P 500
This Quarter Est. Return
+4.62%
1 Year Est. Return
+30.62%
3 Year Est. Return
+51.59%
5 Year Est. Return
+187.25%
10 Year Est. Return
+311.51%
AUM
$2.76B
AUM Growth
+$12.4M
Cap. Flow
-$81.1M
Cap. Flow %
-2.93%
Top 10 Hldgs %
27.85%
Holding
271
New
9
Increased
35
Reduced
133
Closed
22

Sector Composition

1 Healthcare 19.22%
2 Technology 15.12%
3 Industrials 12.53%
4 Financials 11.35%
5 Communication Services 8.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AVNS icon
251
Avanos Medical
AVNS
$1.17B
-16,826
Closed -$583K
AXP icon
252
American Express
AXP
$242B
-5,300
Closed -$339K
ESLT icon
253
Elbit Systems
ESLT
$34.7B
-3,000
Closed -$287K
GLNG icon
254
Golar LNG
GLNG
$5.05B
-281,100
Closed -$5.96M
HONE
255
DELISTED
HarborOne Bancorp
HONE
-217,554
Closed -$1.91M
LPSN icon
256
LivePerson
LPSN
$20.7M
-1,333
Closed -$168K
OXY icon
257
Occidental Petroleum
OXY
$54.6B
-58,830
Closed -$4.29M
SGMO
258
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
-31,750
Closed -$147K
TROW icon
259
T. Rowe Price
TROW
$25.1B
-3,500
Closed -$233K
TSLA icon
260
Tesla
TSLA
$1.43T
-23,850
Closed -$324K
WT icon
261
WisdomTree
WT
$3.07B
-88,550
Closed -$911K
VRN
262
DELISTED
Veren
VRN
-203,350
Closed -$2.68M
NVRO
263
DELISTED
NEVRO CORP.
NVRO
-2,410
Closed -$252K
YTEN
264
DELISTED
Yield10 Bioscience, Inc. Common Stock
YTEN
-80
Closed -$347K
ONCT
265
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
-14
Closed -$16K
ISEE
266
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
-140,775
Closed -$6.49M
CVA
267
DELISTED
Covanta Holding Corporation
CVA
-40,175
Closed -$618K
EQM
268
DELISTED
EQM Midstream Partners, LP
EQM
-114,422
Closed -$8.72M
FMI
269
DELISTED
Foundation Medicine, Inc.
FMI
-9,485
Closed -$221K
ROKA
270
DELISTED
Sorrento Tech, Inc. Common Stock
ROKA
-5,000
Closed -$35K
GRA
271
DELISTED
W.R. Grace & Co.
GRA
-10,850
Closed -$801K

Similar funds

Cannell & Co's Q4 2016 Portfolio in Review

As of Q4 2016, Cannell & Co held 271 positions worth $2.76B, up 0.45% from $2.75B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Cannell & Co's Q4 2016 filing shows 9 new, 35 increased, 133 reduced and 22 closed positions. Its largest new stake was Noble Midstream Partners LP: 550,575 shares worth $19.8M. The largest sale was Level 3 Communications Inc, an estimated $45.4M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 20% a quarter earlier, followed by Technology and Industrials.

  • Cannell & Co's largest Q4 2016 buy was Noble Midstream Partners LP: 550,575 shares worth $19.8M.
  • Cannell & Co added most to Zimmer Biomet in Q4 2016, an estimated $50.6M increase.
  • Cannell & Co's biggest Q4 2016 reduction was Level 3 Communications Inc, cutting an estimated $45.4M.
  • Cannell & Co fully exited EQM Midstream Partners, LP in Q4 2016, selling an estimated $8.72M.
  • Cannell & Co's ten largest holdings make up 28% of its $2.76B portfolio in Q4 2016.
  • Cannell & Co opened 9 new positions and closed 22 in Q4 2016.
  • Cannell & Co's portfolio value rose 0.45% quarter-over-quarter to $2.76B.

Based on Cannell & Co's 13F filing for Q4 2016, filed 13 Feb 2017.